Michael Schmitz
Concepts (305)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiac Surgical Procedures | 8 | 2021 | 318 | 1.410 |
Why?
| Cefazolin | 2 | 2020 | 11 | 1.310 |
Why?
| Antibiotic Prophylaxis | 2 | 2020 | 67 | 1.250 |
Why?
| Heart Defects, Congenital | 8 | 2015 | 608 | 1.000 |
Why?
| Heart-Assist Devices | 6 | 2013 | 147 | 0.870 |
Why?
| Anti-Bacterial Agents | 2 | 2020 | 820 | 0.840 |
Why?
| Filtration | 1 | 2020 | 20 | 0.780 |
Why?
| Pulmonary Valve | 1 | 2021 | 42 | 0.770 |
Why?
| Masks | 1 | 2020 | 31 | 0.760 |
Why?
| Extracorporeal Membrane Oxygenation | 7 | 2016 | 302 | 0.750 |
Why?
| Neuralgia | 1 | 2021 | 58 | 0.730 |
Why?
| Cardiopulmonary Bypass | 7 | 2013 | 97 | 0.730 |
Why?
| Tetralogy of Fallot | 1 | 2021 | 94 | 0.720 |
Why?
| Phlebotomy | 2 | 2016 | 6 | 0.680 |
Why?
| Catheterization, Central Venous | 3 | 2023 | 98 | 0.660 |
Why?
| Lidocaine | 2 | 2016 | 48 | 0.660 |
Why?
| Anesthetics, Local | 2 | 2016 | 74 | 0.640 |
Why?
| Catheterization, Peripheral | 2 | 2016 | 63 | 0.640 |
Why?
| Heart Transplantation | 9 | 2012 | 307 | 0.570 |
Why?
| Renal Replacement Therapy | 1 | 2014 | 45 | 0.500 |
Why?
| Child, Preschool | 20 | 2020 | 4147 | 0.420 |
Why?
| Child | 18 | 2020 | 7341 | 0.390 |
Why?
| Humans | 50 | 2023 | 54284 | 0.390 |
Why?
| Adolescent | 16 | 2020 | 6897 | 0.380 |
Why?
| Tissue Donors | 3 | 2006 | 110 | 0.370 |
Why?
| Intraoperative Complications | 4 | 2010 | 125 | 0.360 |
Why?
| Acute Kidney Injury | 1 | 2014 | 403 | 0.360 |
Why?
| Heparin | 3 | 2013 | 97 | 0.350 |
Why?
| Cholesterol | 1 | 2009 | 155 | 0.340 |
Why?
| Pipecolic Acids | 1 | 2008 | 8 | 0.340 |
Why?
| Cerebral Hemorrhage | 1 | 2009 | 102 | 0.330 |
Why?
| Half-Life | 2 | 2020 | 92 | 0.320 |
Why?
| Area Under Curve | 2 | 2020 | 205 | 0.320 |
Why?
| Monte Carlo Method | 2 | 2020 | 99 | 0.310 |
Why?
| Brain Injuries | 3 | 2015 | 183 | 0.310 |
Why?
| Thrombocytopenia | 1 | 2008 | 99 | 0.310 |
Why?
| Female | 28 | 2020 | 28441 | 0.310 |
Why?
| Infant, Newborn | 15 | 2023 | 2907 | 0.300 |
Why?
| Anticoagulants | 3 | 2013 | 270 | 0.300 |
Why?
| Body Weight | 3 | 2020 | 578 | 0.290 |
Why?
| Male | 27 | 2020 | 27334 | 0.290 |
Why?
| Cardiac Output, High | 1 | 2006 | 3 | 0.280 |
Why?
| Laryngeal Masks | 1 | 2006 | 9 | 0.280 |
Why?
| Methyl Ethers | 1 | 2006 | 18 | 0.280 |
Why?
| Facial Neoplasms | 1 | 2006 | 23 | 0.270 |
Why?
| Anesthetics, Inhalation | 1 | 2006 | 35 | 0.270 |
Why?
| Allied Health Personnel | 1 | 2006 | 33 | 0.270 |
Why?
| Infant | 16 | 2018 | 3817 | 0.270 |
Why?
| Nitric Oxide | 3 | 2017 | 298 | 0.270 |
Why?
| Hemangioma | 1 | 2006 | 83 | 0.250 |
Why?
| Pain Management | 2 | 2016 | 155 | 0.250 |
Why?
| Heart Septal Defects, Atrial | 5 | 2012 | 45 | 0.250 |
Why?
| Models, Biological | 2 | 2020 | 823 | 0.250 |
Why?
| Subclavian Vein | 1 | 2003 | 12 | 0.230 |
Why?
| Central Venous Catheters | 1 | 2023 | 31 | 0.230 |
Why?
| Thoracotomy | 1 | 2003 | 37 | 0.220 |
Why?
| Heart Ventricles | 2 | 2021 | 271 | 0.220 |
Why?
| Brain | 4 | 2015 | 1387 | 0.210 |
Why?
| Scoliosis | 1 | 2003 | 58 | 0.210 |
Why?
| Heparin Antagonists | 2 | 2013 | 7 | 0.200 |
Why?
| Protamines | 2 | 2013 | 9 | 0.200 |
Why?
| Sterilization | 1 | 2020 | 10 | 0.200 |
Why?
| Metabolic Clearance Rate | 1 | 2020 | 75 | 0.190 |
Why?
| Linear Models | 4 | 2016 | 309 | 0.190 |
Why?
| Time Factors | 6 | 2018 | 3213 | 0.190 |
Why?
| Treatment Outcome | 9 | 2017 | 5604 | 0.190 |
Why?
| Pain, Postoperative | 2 | 2016 | 161 | 0.190 |
Why?
| Hemodynamics | 2 | 2017 | 290 | 0.180 |
Why?
| Surgical Procedures, Operative | 1 | 2020 | 78 | 0.180 |
Why?
| Pulmonary Artery | 1 | 2021 | 151 | 0.180 |
Why?
| Occupational Exposure | 1 | 2020 | 129 | 0.170 |
Why?
| Powders | 2 | 2016 | 32 | 0.170 |
Why?
| Retrospective Studies | 10 | 2018 | 6432 | 0.170 |
Why?
| Needles | 2 | 2016 | 30 | 0.170 |
Why?
| Double-Blind Method | 3 | 2016 | 742 | 0.170 |
Why?
| Dose-Response Relationship, Drug | 2 | 2020 | 1476 | 0.170 |
Why?
| Heart Septal Defects, Ventricular | 2 | 2012 | 36 | 0.170 |
Why?
| Jugular Veins | 2 | 2023 | 35 | 0.160 |
Why?
| Adult | 5 | 2021 | 14207 | 0.160 |
Why?
| Databases, Factual | 3 | 2017 | 684 | 0.160 |
Why?
| Logistic Models | 3 | 2017 | 995 | 0.160 |
Why?
| Airway Extubation | 1 | 2018 | 38 | 0.160 |
Why?
| Chi-Square Distribution | 3 | 2014 | 318 | 0.160 |
Why?
| Echocardiography, Transesophageal | 2 | 2012 | 73 | 0.160 |
Why?
| Multivariate Analysis | 3 | 2016 | 643 | 0.160 |
Why?
| Postoperative Care | 1 | 2018 | 121 | 0.160 |
Why?
| Pain Measurement | 2 | 2016 | 246 | 0.150 |
Why?
| Off-Label Use | 1 | 2017 | 27 | 0.150 |
Why?
| Hospitals, Low-Volume | 1 | 2017 | 23 | 0.150 |
Why?
| Hospitals, High-Volume | 1 | 2017 | 35 | 0.150 |
Why?
| Intubation, Intratracheal | 1 | 2018 | 130 | 0.150 |
Why?
| Williams Syndrome | 1 | 2017 | 29 | 0.150 |
Why?
| Shock | 1 | 2017 | 37 | 0.150 |
Why?
| Cardiovascular System | 1 | 2017 | 50 | 0.150 |
Why?
| Death, Sudden, Cardiac | 1 | 2017 | 60 | 0.140 |
Why?
| Pulmonary Circulation | 2 | 2014 | 36 | 0.140 |
Why?
| Pachyonychia Congenita | 1 | 2016 | 1 | 0.140 |
Why?
| Heart Failure | 3 | 2012 | 541 | 0.140 |
Why?
| Premedication | 1 | 2016 | 18 | 0.140 |
Why?
| Anesthesia | 1 | 2017 | 79 | 0.140 |
Why?
| Vasodilator Agents | 1 | 2016 | 111 | 0.140 |
Why?
| Foot | 1 | 2016 | 50 | 0.140 |
Why?
| Administration, Cutaneous | 1 | 2015 | 63 | 0.130 |
Why?
| Pandemics | 1 | 2020 | 579 | 0.130 |
Why?
| Reference Standards | 1 | 2015 | 63 | 0.130 |
Why?
| Hospital Mortality | 2 | 2014 | 465 | 0.130 |
Why?
| Hypertension, Pulmonary | 1 | 2016 | 126 | 0.130 |
Why?
| Blalock-Taussig Procedure | 1 | 2014 | 21 | 0.130 |
Why?
| Quality of Life | 1 | 2021 | 922 | 0.120 |
Why?
| Erythrocyte Transfusion | 1 | 2014 | 74 | 0.120 |
Why?
| Embolism, Air | 2 | 2004 | 12 | 0.120 |
Why?
| Hypoxia-Ischemia, Brain | 1 | 2015 | 69 | 0.120 |
Why?
| Computer Simulation | 1 | 2015 | 332 | 0.120 |
Why?
| Chronic Pain | 1 | 2016 | 147 | 0.120 |
Why?
| Risk Factors | 4 | 2017 | 3935 | 0.110 |
Why?
| Whole Blood Coagulation Time | 1 | 2013 | 6 | 0.110 |
Why?
| Young Adult | 2 | 2020 | 4318 | 0.110 |
Why?
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2013 | 22 | 0.110 |
Why?
| Age Factors | 2 | 2014 | 1198 | 0.110 |
Why?
| Odds Ratio | 1 | 2014 | 604 | 0.110 |
Why?
| Thrombelastography | 1 | 2013 | 28 | 0.110 |
Why?
| Brain Diseases | 1 | 2013 | 87 | 0.110 |
Why?
| Dexmedetomidine | 1 | 2012 | 26 | 0.110 |
Why?
| Femoral Vein | 1 | 2012 | 45 | 0.110 |
Why?
| Pain | 1 | 2015 | 405 | 0.110 |
Why?
| Carotid Arteries | 1 | 2012 | 82 | 0.110 |
Why?
| Renal Artery | 1 | 2012 | 40 | 0.100 |
Why?
| Hepatitis C, Chronic | 1 | 2013 | 89 | 0.100 |
Why?
| Hypnotics and Sedatives | 1 | 2012 | 74 | 0.100 |
Why?
| Hepacivirus | 1 | 2013 | 127 | 0.100 |
Why?
| Career Choice | 1 | 2013 | 116 | 0.100 |
Why?
| Renal Circulation | 1 | 2012 | 82 | 0.100 |
Why?
| Echocardiography, Doppler | 1 | 2012 | 61 | 0.100 |
Why?
| Ketamine | 1 | 2012 | 61 | 0.100 |
Why?
| Critical Illness | 1 | 2014 | 344 | 0.100 |
Why?
| Heart Diseases | 1 | 2014 | 237 | 0.100 |
Why?
| Spherocytosis, Hereditary | 1 | 2010 | 14 | 0.100 |
Why?
| Femoral Artery | 1 | 2012 | 122 | 0.100 |
Why?
| Neuroprotective Agents | 1 | 2012 | 125 | 0.100 |
Why?
| Anti-Inflammatory Agents | 1 | 2012 | 175 | 0.100 |
Why?
| United States | 3 | 2017 | 5217 | 0.090 |
Why?
| Lactates | 1 | 2010 | 34 | 0.090 |
Why?
| Tomography Scanners, X-Ray Computed | 1 | 2009 | 14 | 0.090 |
Why?
| Aged | 3 | 2020 | 10054 | 0.090 |
Why?
| Child Nutrition Disorders | 1 | 2009 | 14 | 0.090 |
Why?
| Cardiac Output | 1 | 2009 | 50 | 0.090 |
Why?
| Nutritional Support | 1 | 2009 | 35 | 0.090 |
Why?
| Cardiomyopathy, Dilated | 1 | 2009 | 41 | 0.090 |
Why?
| Equipment Failure | 1 | 2009 | 70 | 0.090 |
Why?
| Safety Management | 1 | 2009 | 49 | 0.090 |
Why?
| Dipyridamole | 1 | 2008 | 9 | 0.080 |
Why?
| Thrombin | 1 | 2008 | 49 | 0.080 |
Why?
| International Normalized Ratio | 1 | 2008 | 29 | 0.080 |
Why?
| Infusions, Intravenous | 1 | 2008 | 231 | 0.080 |
Why?
| Drug Interactions | 1 | 2008 | 206 | 0.080 |
Why?
| Arkansas | 3 | 2013 | 2100 | 0.080 |
Why?
| Stroke | 1 | 2013 | 526 | 0.080 |
Why?
| Feeding Methods | 1 | 2007 | 18 | 0.080 |
Why?
| Middle Aged | 2 | 2020 | 13088 | 0.080 |
Why?
| Warfarin | 1 | 2008 | 87 | 0.080 |
Why?
| Inflammation | 1 | 2012 | 674 | 0.080 |
Why?
| Vena Cava, Superior | 1 | 2007 | 24 | 0.080 |
Why?
| Vocal Cord Paralysis | 1 | 2007 | 27 | 0.080 |
Why?
| Sulfonamides | 1 | 2008 | 146 | 0.080 |
Why?
| Quality Assurance, Health Care | 2 | 2009 | 164 | 0.080 |
Why?
| Aspirin | 1 | 2008 | 127 | 0.070 |
Why?
| Internship and Residency | 1 | 2013 | 501 | 0.070 |
Why?
| Arginine | 1 | 2008 | 182 | 0.070 |
Why?
| Chronic Disease | 1 | 2009 | 614 | 0.070 |
Why?
| Foreign Bodies | 1 | 2007 | 64 | 0.070 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2008 | 180 | 0.070 |
Why?
| Oximetry | 1 | 2007 | 62 | 0.070 |
Why?
| von Willebrand Diseases | 1 | 2006 | 21 | 0.070 |
Why?
| Cerebrovascular Circulation | 1 | 2007 | 137 | 0.070 |
Why?
| Oxygen Consumption | 1 | 2007 | 223 | 0.070 |
Why?
| Vincristine | 1 | 2006 | 98 | 0.070 |
Why?
| Blood Coagulation Disorders | 1 | 2006 | 37 | 0.070 |
Why?
| Cerebral Cortex | 1 | 2007 | 234 | 0.070 |
Why?
| Prosthesis Implantation | 1 | 2005 | 47 | 0.070 |
Why?
| Vascular Surgical Procedures | 1 | 2007 | 178 | 0.060 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2006 | 87 | 0.060 |
Why?
| Length of Stay | 1 | 2008 | 683 | 0.060 |
Why?
| Analgesia | 1 | 2004 | 14 | 0.060 |
Why?
| Embolectomy | 1 | 2004 | 15 | 0.060 |
Why?
| Perioperative Care | 1 | 2004 | 42 | 0.060 |
Why?
| Heart Arrest, Induced | 1 | 2004 | 5 | 0.060 |
Why?
| Combined Modality Therapy | 2 | 2016 | 692 | 0.060 |
Why?
| Extracorporeal Circulation | 1 | 2004 | 11 | 0.060 |
Why?
| Advanced Cardiac Life Support | 1 | 2004 | 11 | 0.060 |
Why?
| Heart Septum | 1 | 2004 | 24 | 0.060 |
Why?
| Esophagoscopy | 1 | 2004 | 26 | 0.060 |
Why?
| Heart Injuries | 1 | 2004 | 20 | 0.060 |
Why?
| Shock, Cardiogenic | 1 | 2004 | 29 | 0.060 |
Why?
| Oxygenators, Membrane | 1 | 2003 | 3 | 0.060 |
Why?
| Esophageal Diseases | 1 | 2004 | 24 | 0.060 |
Why?
| Hospitals, Pediatric | 1 | 2005 | 272 | 0.060 |
Why?
| Diagnostic Imaging | 1 | 2005 | 184 | 0.060 |
Why?
| Tissue and Organ Procurement | 1 | 2004 | 39 | 0.060 |
Why?
| Cattle | 1 | 2004 | 224 | 0.060 |
Why?
| Esophagus | 1 | 2004 | 79 | 0.060 |
Why?
| Pleural Cavity | 1 | 2003 | 3 | 0.060 |
Why?
| Catheters, Indwelling | 1 | 2023 | 68 | 0.060 |
Why?
| Pulmonary Embolism | 1 | 2004 | 106 | 0.060 |
Why?
| Necrosis | 1 | 2023 | 208 | 0.060 |
Why?
| Wounds, Nonpenetrating | 1 | 2004 | 91 | 0.060 |
Why?
| Edema | 1 | 2023 | 74 | 0.060 |
Why?
| Incidence | 2 | 2018 | 1082 | 0.060 |
Why?
| Postoperative Period | 2 | 2017 | 189 | 0.050 |
Why?
| Cognition Disorders | 1 | 2004 | 240 | 0.050 |
Why?
| Prospective Studies | 3 | 2014 | 2604 | 0.050 |
Why?
| Ultrasonography | 3 | 2012 | 480 | 0.050 |
Why?
| Magnetic Resonance Imaging | 3 | 2015 | 1604 | 0.050 |
Why?
| Radiography | 1 | 2003 | 524 | 0.050 |
Why?
| Follow-Up Studies | 4 | 2013 | 2387 | 0.050 |
Why?
| Pneumonia, Viral | 1 | 2004 | 184 | 0.050 |
Why?
| Athletic Injuries | 1 | 2004 | 225 | 0.050 |
Why?
| Heart | 1 | 2004 | 360 | 0.050 |
Why?
| Pilot Projects | 2 | 2014 | 808 | 0.050 |
Why?
| Regression Analysis | 2 | 2013 | 445 | 0.050 |
Why?
| Spectroscopy, Near-Infrared | 2 | 2012 | 62 | 0.040 |
Why?
| Analgesics, Opioid | 1 | 2004 | 501 | 0.040 |
Why?
| Cardiac Catheterization | 2 | 2012 | 258 | 0.040 |
Why?
| Administration, Inhalation | 1 | 2016 | 119 | 0.040 |
Why?
| Illinois | 1 | 2016 | 15 | 0.040 |
Why?
| Placebo Effect | 1 | 2016 | 19 | 0.040 |
Why?
| Drug Compounding | 1 | 2016 | 28 | 0.040 |
Why?
| Administration, Topical | 1 | 2016 | 71 | 0.030 |
Why?
| Hematocrit | 1 | 2014 | 51 | 0.030 |
Why?
| Anisotropy | 1 | 2014 | 63 | 0.030 |
Why?
| Survival Rate | 1 | 2016 | 951 | 0.030 |
Why?
| Preoperative Care | 1 | 2015 | 184 | 0.030 |
Why?
| Equipment Design | 2 | 2005 | 318 | 0.030 |
Why?
| Diffusion Tensor Imaging | 1 | 2014 | 97 | 0.030 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 126 | 0.030 |
Why?
| Electroencephalography | 1 | 2015 | 356 | 0.030 |
Why?
| Case Management | 1 | 2013 | 45 | 0.030 |
Why?
| Intention to Treat Analysis | 1 | 2012 | 28 | 0.030 |
Why?
| Pulsatile Flow | 1 | 2012 | 18 | 0.030 |
Why?
| Hip | 1 | 2012 | 26 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2012 | 232 | 0.030 |
Why?
| Prosthesis Design | 1 | 2013 | 262 | 0.030 |
Why?
| Vascular Resistance | 1 | 2012 | 60 | 0.030 |
Why?
| Injections, Intravenous | 1 | 2012 | 148 | 0.030 |
Why?
| Patient Positioning | 1 | 2012 | 35 | 0.030 |
Why?
| Rotation | 1 | 2012 | 76 | 0.030 |
Why?
| Body Height | 1 | 2012 | 76 | 0.030 |
Why?
| Regional Blood Flow | 1 | 2012 | 121 | 0.030 |
Why?
| Risk Assessment | 1 | 2017 | 1361 | 0.030 |
Why?
| Blood Flow Velocity | 1 | 2012 | 114 | 0.030 |
Why?
| Septal Occluder Device | 1 | 2012 | 29 | 0.030 |
Why?
| Patient Safety | 1 | 2012 | 121 | 0.030 |
Why?
| Central Nervous System | 1 | 2012 | 85 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2012 | 401 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2012 | 159 | 0.020 |
Why?
| Hematologic Tests | 1 | 2010 | 11 | 0.020 |
Why?
| Feasibility Studies | 1 | 2012 | 398 | 0.020 |
Why?
| Gestational Age | 1 | 2012 | 435 | 0.020 |
Why?
| Child Development | 1 | 2012 | 204 | 0.020 |
Why?
| Prevalence | 1 | 2013 | 1025 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2013 | 1084 | 0.020 |
Why?
| Anesthesia, General | 1 | 2010 | 96 | 0.020 |
Why?
| Infant, Premature | 1 | 2012 | 335 | 0.020 |
Why?
| Case-Control Studies | 1 | 2012 | 1228 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2012 | 1048 | 0.020 |
Why?
| Cytokines | 1 | 2012 | 676 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 3431 | 0.020 |
Why?
| Prognosis | 1 | 2013 | 2118 | 0.020 |
Why?
| Cohort Studies | 1 | 2012 | 1543 | 0.020 |
Why?
| Intubation, Gastrointestinal | 1 | 2007 | 27 | 0.020 |
Why?
| Gastrostomy | 1 | 2007 | 60 | 0.020 |
Why?
| Laryngoscopy | 1 | 2007 | 62 | 0.020 |
Why?
| Aorta, Thoracic | 1 | 2007 | 90 | 0.020 |
Why?
| Tracheostomy | 1 | 2007 | 81 | 0.020 |
Why?
| Coagulants | 1 | 2006 | 3 | 0.020 |
Why?
| Factor VIII | 1 | 2006 | 28 | 0.020 |
Why?
| Atrial Flutter | 1 | 2005 | 10 | 0.020 |
Why?
| Postoperative Hemorrhage | 1 | 2006 | 53 | 0.020 |
Why?
| Cyanosis | 1 | 2004 | 14 | 0.020 |
Why?
| Ventilation-Perfusion Ratio | 1 | 2004 | 7 | 0.020 |
Why?
| Ligation | 1 | 2004 | 64 | 0.020 |
Why?
| Enoxaparin | 1 | 2004 | 25 | 0.020 |
Why?
| Emergencies | 1 | 2004 | 92 | 0.020 |
Why?
| Ventricular Outflow Obstruction | 1 | 2004 | 24 | 0.020 |
Why?
| Hypopharynx | 1 | 2004 | 4 | 0.020 |
Why?
| Cardioplegic Solutions | 1 | 2004 | 2 | 0.020 |
Why?
| Arm | 1 | 2004 | 52 | 0.020 |
Why?
| Infarction, Middle Cerebral Artery | 1 | 2004 | 44 | 0.020 |
Why?
| Ductus Arteriosus, Patent | 1 | 2004 | 37 | 0.020 |
Why?
| Mucous Membrane | 1 | 2004 | 33 | 0.020 |
Why?
| Suture Techniques | 1 | 2004 | 70 | 0.010 |
Why?
| Risk | 1 | 2004 | 343 | 0.010 |
Why?
| Equipment Failure Analysis | 1 | 2003 | 49 | 0.010 |
Why?
| Veins | 1 | 2004 | 74 | 0.010 |
Why?
| Ischemia | 1 | 2004 | 177 | 0.010 |
Why?
| Pressure | 1 | 2003 | 120 | 0.010 |
Why?
| Monitoring, Physiologic | 1 | 2004 | 136 | 0.010 |
Why?
| Coronary Artery Bypass | 1 | 2004 | 134 | 0.010 |
Why?
| Palliative Care | 1 | 2004 | 188 | 0.010 |
Why?
| Blood Vessel Prosthesis Implantation | 1 | 2004 | 129 | 0.010 |
Why?
| Drug Delivery Systems | 1 | 2004 | 151 | 0.010 |
Why?
| Sepsis | 1 | 2004 | 251 | 0.010 |
Why?
| Blood Pressure | 1 | 2003 | 587 | 0.010 |
Why?
| Diagnosis, Differential | 1 | 2004 | 1136 | 0.010 |
Why?
| Algorithms | 1 | 2003 | 697 | 0.010 |
Why?
| Animals | 1 | 2004 | 14385 | 0.000 |
Why?
|
|
Schmitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|